During the past decade, AIO-Studien-gGmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AIO-Studien-gGmbH" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator, "WiSP Wissenschaftlicher Service Pharma GmbH" with 1 trials as a collaborator and "iOMEDICO AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "AIO-Studien-gGmbH" are "Colorectal Neoplasms" (2 trials), "Gastroesophageal Junction Neoplasms" (1 trials) and "Stomach Neoplasms" (1 trials). Many other conditions were trialed in "AIO-Studien-gGmbH" in a lesser frequency.

Most popular intervention types in "AIO-Studien-gGmbH" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab" (1 trials), "Epirubicin, Cisplatin, Capecitabine" (1 trials), "Epirubicin, Cisplatin, Capecitabine, Panitumumab" (1 trials), "Oxaliplatin, Capecitabine" (1 trials) and "Oxaliplatin, Capecitabine, Panitumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "AIO-Studien-gGmbH" are 3 trials for "All" genders.

Currently, there are NaN active trials in "AIO-Studien-gGmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in AIO-Studien-gGmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AIO-Studien-gGmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".